A biotechnology company, pursuing commercial opportunities in: out-licensing its non-coding patents globally; expanding genetic service-testing business in the Asia-Pacific Region; & supporting research projects in which it is already involved.


Updates from The Motley Fool

Latest updates on Genetic Technologies from Fool.com.


Stock Performance

View Interactive GENE Charts
Sponsored by

Key Data Points

Primary metrics and data points about Genetic Technologies.
Current Price: $1.08
Prev Close: $1.09
Open: $1.08
Bid: $1.08
Ask: $1.09
Day's Range: $1.08 - $1.11
52wk Range: $1.04 - $2.89
Volume: 74,530
Avg Vol 174,415
Market Cap: $18M
P/E (ttm): -0.41
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Genetic Technologies.
CAPS Rating 1 out of 5
 
30 Outperform
65 Underperform
CAPS All Stars
 
2 Outperform
36 Underperform

How do you think Genetic Technologies will perform against the market?



You pick for Genetic Technologies is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Alison Mew, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Genetic Technologies.

A biotechnology company, pursuing commercial opportunities in: out-licensing its non-coding patents globally; expanding genetic service-testing business in the Asia-Pacific Region; & supporting research projects in which it is already involved.

  • Exchange: NASDAQ
  • Sector: Services
  • Industry: Diversified Services